China is a key growth driver and enabler to the Alexion 2030 ambition. China’s rare disease market has expanded rapidly over the past five years, while its access and reimbursement framework continues to evolve. Further development of dedicated rare disease policies, funding mechanisms, and an integrated access ecosystem will be important to recognize innovation and support sustainable patient access. The Alexion China strategic Access Lead is expected to play a strategic role in unlocking for China new innovative access opportunities and solutions to enable sustained expansion of Alexion’s portfolio in the country With a strong understanding of both the China specific environment and the rare diseases market access eco systems across key countries, closely collaborating with local country market access & corporate affairs teams, GVAP leadership team and other relevant global/regional cross functional teams, he/she plays a pivotal role in stimulating, shaping & enabling implementation of new market access strategy and solutions that would facilitate the successful establishment in China of a rare diseases specific market access eco-system. Based in Barcelona, the GVAP China strategic Access lead will work in close collaboration with both the AZ China team leading the integrated multifunction rare diseases market access-advocacy strategy (market access, corporate affairs, HeOR, medical, commercial, etc....) , GVAP leadership team and the relevant global/regional cross functional teams ( Corporate Affairs, medical, HeOR….). With his/her in-depth knowledge of the the rare diseases market access eco systems across key countries, he/she provides strategic Market access support to the China Rare Diseases team through the following main activities: · For China & provinces in scope, he/she provides hands on experience and strategic guidance in establishing and driving an actionable cross-function Market Access & Pricing policy framework to accompany and reinforce local access strategy development and implementation. This includes, for example supporting development of access-pricing policy priority objectives and defining corresponding access strategy objectives and related priority workstreams. · In close collaboration & alignment with AZ China team, he/she supports, explores, proposes strategic access initiatives to unlock China rare diseases and/or payer policy to open opportunities to the successful establishment in China of a rare diseases specific market access & pricing eco-system. This includes supporting development and/or participating to local stakeholder engagement events, developing relevant RD narrative and/or access strategy position papers for external engagement with payers, government officials and other key stakeholders to enable the successful establishment in China of a rare diseases specific market access & pricing eco-system · He/she supports strategic access capability building at country level by sharing best practices, co-developing and proactively providing tailored operational support necessary for the China teams to effectively navigate the RD landscape. Experience · proven market access experience working in constructing & implementing access & pricing strategies with confirmed examples of success through cross functional work and collaboration · Understanding of the access and policy environment for rare diseases and/or specialized medicines in China · Preferably China country market expertise/experience · Experience of cross-functional project development and management · Prior rare disease or specialized drugs therapy area expertise. · Relevant drug development and/or commercialization experience within the pharmaceutical/medical industry. Capabilities & skills - This role requires · ability to work across functions and mobilize positive relationships to effectively collaborate internally with both AZ China teams and relevant global cross functions · ability and demonstrated experience to engage externally with payers and other access stakeholders · Excellent track-record of managing and/or working in cross-functional projects, being able to integrate cross functional input into a consistent integrated strategy platform · In country and/or above country market access expertise/experience · highly autonomous and effective communicators with cultural sensitivity and engagement skills across the diversity of Asia markets in scope · strategic planning capabilities & Ability to deal with complexity (China, portfolio, diseases) · Master Degree or higher education including strong scientific background · Fluency in Mandarin Chinese and English is HIGHLY DESIRED Date Posted 15-Oct-2026 Closing Date 14-Oct-2026 Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify. For over three decades, patients and their caregivers have been at the center of everything we do. Every day, we are inspired to follow the science and think differently to create better outcomes for them and their families. Our mission is driven by understanding who they are as unique individuals, not solely defined by their diseases. We’re a leading rare disease company with a diversified projects. Our pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into transformative medicines over the past three decades. Today, we continue to push the boundaries of science and deepen our understanding of rare diseases with patient-centricity at the core. This knowledge allows us to innovate and evolve into new areas where needs are unmet and provide an opportunity to help people fully live their best lives.

China Strategic Market Access Lead.

more at Astrazeneca.

Patient Safety Lead

［Alexion Japan］Director, Medical Lead, Neurology

【Alexion Japan】Associate Director, Nephrology Marketing

similar roles.

Vice President, Wealth Sales

Senior Manager, Sales Operations & Enablement

Founding Sales Manager

Enterprise Account Executive

Marketing Lead

Sales Executive - Owo